Papp, Z. Et Al. 2012. Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan. INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.159, no.2 , 82-87.

Papp, Z., Edes, I., Fruhwald, S., De Hert, S. G., Salmenpera, M., Leppikangas, H., ... Mebazaa, A.(2012). Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan. INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.159, no.2, 82-87.

Papp, Zoltan Et Al. "Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan," INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.159, no.2, 82-87, 2012

Papp, Zoltan Et Al. "Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan." INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.159, no.2, pp.82-87, 2012

Papp, Z. Et Al. (2012) . "Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan." INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.159, no.2, pp.82-87.

@article{article, author={Zoltan Papp Et Al. }, title={Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan}, journal={INTERNATIONAL JOURNAL OF CARDIOLOGY}, year=2012, pages={82-87} }